Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. isothermal instrument
Show results for
Products
Software

Companies

News
Downloads

Refine by
Date

  • Older

Isothermal Instrument Articles & Analysis

11 news found

Inflammatix Appoints Dr. Kian Beyzavi as New Board Member

Inflammatix Appoints Dr. Kian Beyzavi as New Board Member

Future tests will be developed to run on the company’s sample-to-answer isothermal instrument platform in under 30 minutes, enabling the power of precision medicine at the point of care. ...

ByInflammatix, Inc.


Inflammatix Announces Additional $12.1 Million Funding from BARDA for ViraBac EZ Acute Infection Test

Inflammatix Announces Additional $12.1 Million Funding from BARDA for ViraBac EZ Acute Infection Test

Each test will be developed to run on the company’s sample-to-answer isothermal instrument platform in under 30 minutes, enabling the power of precision medicine at the point of care. ...

ByInflammatix, Inc.


Inflammatix Awarded $1.7 Million Grant From National Institutes of Health (NIH)

Inflammatix Awarded $1.7 Million Grant From National Institutes of Health (NIH)

Future tests will be developed to run on the company’s sample-to-answer isothermal instrument platform in under 30 minutes, enabling the power of precision medicine at the point of care. ...

ByInflammatix, Inc.


Inflammatix Appoints Amy Boyle as Chief Operating Officer

Inflammatix Appoints Amy Boyle as Chief Operating Officer

“With our impending commercial launch, Amy’s insights and leadership will be instrumental in setting up Inflammatix for continued success now and into the ...

ByInflammatix, Inc.


Inflammatix Secures $102 Million in Series D Financing Led by D1 Capital Partners to Commercialize Novel Host Response Diagnostics

Inflammatix Secures $102 Million in Series D Financing Led by D1 Capital Partners to Commercialize Novel Host Response Diagnostics

Each test will be developed to run on the company’s sample-to-answer isothermal instrument platform, Myrna, in under 30 minutes, enabling the power of precision medicine at the point of care. ...

ByInflammatix, Inc.


Inflammatix Announces $7.4 Million in Additional BARDA Funding to Advance ViraBac EZ Acute Infection Test

Inflammatix Announces $7.4 Million in Additional BARDA Funding to Advance ViraBac EZ Acute Infection Test

“We are pleased to continue to partner with BARDA in the development of our ViraBac EZ test and Myrna instrument. Enabling physicians to make more informed decisions about which patients need antibiotics and which can avoid them has the potential to transform patient care at the point of care,” said Tim Sweeney, M.D., Ph.D., co-founder and chief executive officer of ...

ByInflammatix, Inc.


DARPA Awards Inflammatix up to $1.1 Million to Develop Diagnostic that Predicts COVID-19 Severity Risk

DARPA Awards Inflammatix up to $1.1 Million to Develop Diagnostic that Predicts COVID-19 Severity Risk

Future tests will be developed to run on the company’s sample-to-answer isothermal instrument platform, MyrnaTM, in under 30 minutes, enabling the power of precision medicine at the point of care. ...

ByInflammatix, Inc.


Study Demonstrates Substantial Cost Savings in Health Economic Model of the Inflammatix Host-Response Test for Sepsis

Study Demonstrates Substantial Cost Savings in Health Economic Model of the Inflammatix Host-Response Test for Sepsis

Each test will be developed to run on the company’s sample-to-answer isothermal instrument platform in under 30 minutes, enabling the power of precision medicine at the point of care. ...

ByInflammatix, Inc.


Inflammatix Appoints João Fonseca, Ph.D., as Chief Technology Officer

Inflammatix Appoints João Fonseca, Ph.D., as Chief Technology Officer

Each test will be developed to run on the company’s sample-to-answer isothermal instrument platform in under 30 minutes, enabling the power of precision medicine at the point of care. ...

ByInflammatix, Inc.


New Inflammatix Study in Nature Communications Outlines Breakthrough in Diagnosing Acute Infections by Reading the Immune System

New Inflammatix Study in Nature Communications Outlines Breakthrough in Diagnosing Acute Infections by Reading the Immune System

Each test will be developed to run on the company’s sample-to-answer isothermal instrument platform in under 30 minutes, enabling the power of precision medicine at the point of care. ...

ByInflammatix, Inc.


Inflammatix Announces $32 Million in Series C Funding

Inflammatix Announces $32 Million in Series C Funding

Each test will be developed to run on the company’s sample-to-answer isothermal instrument platform in under 30 minutes, enabling the power of precision medicine at the point of care. ...

ByInflammatix, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT